Balyasny Asset Management
ORGO icon

Balyasny Asset Management’s Organogenesis Holdings ORGO Stock Holding History

Balyasny Asset Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-261,915
Closed -$1.36M – 3351
2025
Q4 		$1.36M Buy
+261,915
New +$1.27M ﹤0.01% 2053
2025
Q3 		– Sell
-28,473
Closed -$104K – 3325
2025
Q2 		$104K Buy
+28,473
New +$106K ﹤0.01% 2683
2021
Q4 		– Sell
-888,464
Closed -$12.7M – 2506
2021
Q3 		$12.7M Buy
+888,464
New +$13.8M 0.05% 489

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Balyasny Asset Management's ORGO Position: Q1 2026 in Review

Balyasny Asset Management sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 261,915 shares — an estimated $1.36M sold.

Balyasny Asset Management first reported a position in ORGO in Q3 2021 and held it in 3 quarters. The position peaked at $12.7M in Q3 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • Balyasny Asset Management reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
  • Balyasny Asset Management sold 261,915 Organogenesis Holdings shares in Q1 2026, an estimated $1.36M.
  • Balyasny Asset Management first reported a position in Organogenesis Holdings in Q3 2021 and held it in 3 quarters.
  • Balyasny Asset Management's Organogenesis Holdings position peaked at $12.7M in Q3 2021.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.